Skip Navigation

Cardiovascular Research 1997 33(2):324-331; doi:10.1016/S0008-6363(96)00236-2
© 1997 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kluge, A.
Right arrow Articles by Schaper, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kluge, A.
Right arrow Articles by Schaper, W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1997, European Society of Cardiology

Coordinate expression of the insulin-like growth factor system after microembolisation in porcine heart

Angelika Kluge, René Zimmermann*, Dorothée Weihrauch, Masahiro Mohri, Stefan Sack, Jutta Schaper and Wolfgang Schaper

Max Planck Institute for Physiological and Clinical Research, Department of Experimental Cardiology, Bad Nauheim, Germany

Objectives: Coronary microembolisation in the pig heart induces angiogenesis in a model of sterile inflammation due to focal necrosis. We have recently shown in this model that insulin-like growth factor I (IGF-I) is involved in inflammation-linked angiogenic processes due to its enhanced transcription after 72 h of ischaemia by infiltrating monocytes in areas of microsphere-induced focal necrosis where capillary sprouting could be detected. To obtain further insights into this process we studied by means of Northern blot analysis and in situ hybridisation the gene expression of other members of the IGF family, i.e. the six IGF binding proteins (IGFBPs), the insulin receptor, and the type I IGF receptor. Methods: Myocardial injury was induced by injection of 25 µm non-radioactive microspheres into the left circumflex artery (LCx) in pigs that were killed after 3–24, 72, or 168 h of microembolisation. Tissue was collected from a non-ischaemic control area and the LCx region of the same heart for further analysis. Results: We found decreased IGFBP-5 (2.7-fold; P<0.02) mRNA concentrations after 72 h of microembolisation in ischaemic tissue versus control tissue from the same heart, preceded by a 1.9-fold elevated level of IGFBP-3 mRNA at 3–24 h (P<0.05). IGFBP-6 was increased in ischaemic tissue at all time points studied. In situ hybridisation identified myocytes as the main producers of IGFBP-3 and IGFBP-6 mRNA. The mRNA levels of IGFBP-2, IGFBP-4, the insulin receptor, and the type I IGF receptor were constitutively expressed but did not change after microembolisation. Neither in heart nor in other organs studied transcripts of IGFBP-1 could be detected. Furthermore, we demonstrated that mRNA of the other components of the IGF system was expressed in almost all porcine organs except liver. Conclusion: These results indicate a coordinate gene expression of the IGF system in microembolised porcine myocardium, compatible with a role of IGF-I, IGFBP-3, IGFBP-5, and IGFBP-6 in inflammation-linked angiogenesis and/or repair processes.

KEYWORDS Myocardial ischemia; Myocardial infarction; Gene expression; Insulin-like growth factor I; IGF binding proteins; Pig, ventricle


* Corresponding author. Max Planck Institute, Department of Experimental Cardiology, Benekestrasse 2, D-61231 Bad Nauheim, Germany. Tel.: (+49-6032) 705-402 or 404; Fax: (+49-6032) 705-419; E-mail: rzimmer@kerckhoff.mpg.de


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
M. Yazdanpanah, F. A Sayed-Tabatabaei, J. A M J L Janssen, I. Rietveld, A. Hofman, T. Stijnen, H. A P Pols, S. W J Lamberts, J. C M Witteman, and C. M van Duijn
IGF-I gene promoter polymorphism is a predictor of survival after myocardial infarction in patients with type 2 diabetes.
Eur. J. Endocrinol., November 1, 2006; 155(5): 751 - 756.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
E. R. Schwarz, D. A. Meven, N. Z. Sulemanjee, P. H. Kersting, T. Tussing, E. C. Skobel, P. Hanrath, and B. F. Uretsky
Monocyte Chemoattractant Protein 1-Induced Monocyte Infiltration Produces Angiogenesis but Not Arteriogenesis in Chronically Infarcted Myocardium
Journal of Cardiovascular Pharmacology and Therapeutics, October 1, 2004; 9(4): 279 - 289.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Delafontaine, Y.-H. Song, and Y. Li
Expression, Regulation, and Function of IGF-1, IGF-1R, and IGF-1 Binding Proteins in Blood Vessels
Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 435 - 444.
[Abstract] [Full Text]


Home page
Mayo Clin Proc.Home page
D. E. Meyers and R. C. Cuneo
Controversies Regarding the Effects of Growth Hormone on the Heart
Mayo Clin. Proc., December 1, 2003; 78(12): 1521 - 1526.
[Abstract] [PDF]


Home page
HeartHome page
G Heusch and R Schulz
Pathophysiology of coronary microembolisation
Heart, September 1, 2003; 89(9): 981 - 982.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Conti, F. Andreotti, A. Sciahbasi, P. Riccardi, G. Marra, E. Menini, G. Ghirlanda, and A. Maseri
Markedly reduced insulin-like growth factor-1 in the acute phase of myocardial infarction
J. Am. Coll. Cardiol., July 1, 2001; 38(1): 26 - 32.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Bayes-Genis, C. A. Conover, and R. S. Schwartz
The Insulin-Like Growth Factor Axis : A Review of Atherosclerosis and Restenosis
Circ. Res., February 4, 2000; 86(2): 125 - 130.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. M Goncalves
Angiogenic growth factors: potential new treatment for acute myocardial infarction?
Cardiovasc Res, January 14, 2000; 45(2): 294 - 302.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. R Kersten, P. S Pagel, W. M Chilian, and D. C Warltier
Multifactorial basis for coronary collateralization: a complex adaptive response to ischemia
Cardiovasc Res, July 1, 1999; 43(1): 44 - 57.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
R. Dean, S. R. Edmondson, L. M. Burrell, and L. A. Bach
Localization of the Insulin-like Growth Factor System in a Rat Model of Heart Failure Induced by Myocardial Infarction
J. Histochem. Cytochem., May 1, 1999; 47(5): 649 - 660.
[Abstract] [Full Text]


Home page
Neuro Oncol DukeHome page
H. Hirano, M. B. S. Lopes, E. R. Laws Jr., T. Asakura, M. Goto, J. E. Carpenter, L. R. Karns, and S. R. VandenBerg
Insulin-like growth factor-1 content and pattern of expression correlates with histopathologic grade in diffusely infiltrating astrocytomas
Neuro-oncol, April 1, 1999; 1(2): 109 - 119.
[Abstract] [PDF]


Home page
Hum Exp ToxicolHome page
V Gersl, J Cerman, P Suba, Y Mazurova, R Hrdina, and J Machackova
IGF-I in experimental daunorubicin-induced cardiomyopathy in rabbits
Human and Experimental Toxicology, March 1, 1999; 18(3): 154 - 161.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Weihrauch, J. Tessmer, D. C. Warltier, and W. M. Chilian
Repetitive coronary artery occlusions induce release of growth factors into the myocardial interstitium
Am J Physiol Heart Circ Physiol, September 1, 1998; 275(3): H969 - H976.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.